The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells

Experimental Cell Research

Volumn 297, Issue 2, 2004, Pages 585-592

  Filion, Christine ^b   Labelle, Yves ^a  

^a Université Laval   (Canada)

^b NONE

Author keywords

CFK2; Chondrogenesis; EWS NOR 1; Extraskeletal myxoid chondrosarcoma; Transformation

Indexed keywords

AGAROSE; HYBRID PROTEIN; NOR 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOLISTIC TRANSFORMATION; CARTILAGE CELL; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; CHONDROGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR DYNAMICS; ONCOGENE; PRIORITY JOURNAL; PROTEIN STABILITY;

EID: 2942735023     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.03.040     Document Type: Article

References (48)

1. Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., de Jong P., Rouleau G., Aurias A., Thomas G. Gene fusion with an ETS-binding domain caused by chromosome translocation in human tumours. Nature. 359:1992;162-165
2. Sorensen P.H.B., Lessnick S.L., Lopez-Terrada D., Liu X.F., Triche T.J., Denny C. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-transcription factor, ERG. Nat. Genet. 6:1994;146-151
3. Jeon I.S., Davis J.N., Braun B.S., Sublett J.E., Roussel M.F., Denny C.T., Shapiro D.N. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 10:1995;1229-1234
4. Kaneko Y., Yoshida K., Handa M., Toyoda Y., Nishihira H., Tanaka Y., Sasaki Y., Ishida S., Higashino F., Fujinaga K. Fusion of an ETS-family gene, E1AF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes, Chromosomes Cancer. 15:1996;115-121
5. Peter M., Couturier J., Pacquement H., Michon J., Thomas G., Magdelenat H., Delattre O. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene. 14:1997;1159-1164
6. Zucman J., Delattre O., Desmaze C., Epstein A.L., Stenman G., Speleman F., Fletchers C.D.M., Aurias A., Thomas G. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat. Genet. 4:1993;341-345
7. Ladanyi M., Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 54:1994;2837-2840
8. Labelle Y., Zucman J., Stenman G., Kindblom L.G., Knight J., Turc-Carel C., Dockhorn-Dworniczak B., Mandahl N., Desmaze C., Peter M., Aurias A., Delattre O., Thomas G. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum. Mol. Genet. 4:1995;2219-2226
9. Panagopoulos I., Höglund M., Mertens F., Mandahl N., Mitelman F., Aman P. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene. 12:1996;489-494
10. Mastrangelo T., Modena P., Tornielli S., Bullrich F., Testi M.A., Mezzelani A., Radice P., Azzarelli A., Pilotti S., Croce C.M., Pierotti M.A., Sozzi G. A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene. 19:2000;3799-3804
11. Ohno T., Ouchida M., Lee L., Gatalica Z., Roa V.N., Reddy E.S.P. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene. 9:1994;3087-3097
12. II68, and subunits of TFIID and RNA polymerase II complex. Mol. Cell. Biol. 18:1998;1489-1497
13. Araya N., Hirota K., Shimamoto Y., Miyagishi M., Yoshida E., Ishida J., Kaneko S., Kaneko M., Nakajima T., Fukamizu A. Cooperative interaction of EWS with CREB- binding protein selectively activates hepatocyte nuclear factor 4-mediated transcription. J. Biol. Chem. 278:2003;5427-5432
14. May W.A., Lessnick S.L., Braun B.S., Klemsz M., Lewis B.C., Lunsford L.B., Hromas R., Denny C.T. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13:1993;7393-7398
15. Ohno T., Rao V.N., Reddy E.S.P. EWS/FLI-1 Chimeric protein is a transcriptional activator. Cancer Res. 53:1993;5859-5863
16. Bailly R.A., Bosselut R., Zucman J., Cormier F., Delattre O., Roussel M., Thomas G., Ghysdael J. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein from the t(11;22) translocation in Ewing sarcoma. Mol. Cell. Biol. 14:1994;3230-3241
17. Knoop L.L., Baker S.J. The splicing factor U1C represses EWS/FLI-mediated transactivation. J. Biol. Chem. 275:2000;24865-24871
18. Yang L., Chansky H.A., Hickstein D.D. EWS/FLI-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing. J. Biol. Chem. 275:2000;37612-37618
19. Knoop L.L., Baker S.J. EWS/FLI alters 5′-splice site selection. J. Biol. Chem. 276:2001;22317-22322
20. Ouchida M., Ohno T., Fujimura Y., Rao V.N., Reddy E.S.P. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene. 11:1995;1049-1054
21. Kovar H., Aryee D.N., Jug G., Henockl C., Schemper M., Delattre O., Thomas G., Gadner H. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Differ. 7:1996;429-437
22. Tanaka K., Iwakuma T., Harimaya K., Sato H., Iwamoto Y. EWS-FLI1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J. Clin. Invest. 99:1997;239-247
23. Fujimura Y., Ohno T., Siddique H., Lee L., Rao V.N., Reddy E.S.P. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene. 12:1996;159-167
24. Bosilevac J.M., Olsen R.J., Bridge J.A., Hinrinchs S.H. Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein. J. Biol. Chem. 274:1999;34811-34818
25. Kim J., Lee K., Pelletier J. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties. Oncogene. 16:1998;1973-1979
26. Karnieli E., Werner H., Rauscher F.J., Benjamin L.E., LeRoith D. The IGF-I receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein. J. Biol. Chem. 271:1996;19304-19309
27. Lee S.B., Kolquist K.A., Nichols K., Englert C., Maheswaran S., Ladanyi M., Gerald W.L., Haber D.A. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round cell tumour. Nat. Genet. 17:1997;309-312
28. Palmer R.E., Lee S.B., Wong J.C., Reynolds P.A., Zhang H., Truong V., Oliner J.D., Gerald W.L., Haber D.A. Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. Cancer Cells. 2:2002;497-505
29. Labelle Y., Bussières J., Courjal F., Goldring M.B. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator. Oncogene. 18:1999;3303-3308
30. Maltais A., Filion C., Labelle Y. The AF2 domain of the orphan nuclear receptor TEC is essential for the transcriptional activity of the oncogenic fusion protein EWS/TEC. Cancer Lett. 183:2002;87-94
31. Laflamme C., Filion C., Bridge J.A., Ladanyi M., Goldring M.B., Labelle Y. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas. Cancer Res. 63:2003;449-454
32. Ohkura N., Yaguchi H., Tsukada T., Yamaguchi K. The EWS/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing. J. Biol. Chem. 277:2002;535-543
33. Maltais A., Labelle Y. Structure and expression of the mouse gene encoding the orphan nuclear receptor TEC. DNA Cell Biol. 19:2000;121-130
34. Hedvat C.V., Irving S.G. The isolation and characterization of MINOR, a novel mitogen-induced nuclear orphan receptor. Mol. Endocrinol. 9:1995;1692-1700
35. Cheng L.E.C., Chan F.K.M., Cado D., Winoto A. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J. 16:1997;1865-1875
36. Martinez-Gonzalez J., Rius J., Castello A., Cases-Langhoff C., Badimon L. Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation. Circ. Res. 92:2003;96-103
37. Ponnio T., Burton Q., Pereira F.A., Wu D.K., Conneely O.M. The nuclear receptor Nor-1 is essential for proliferation of the semicircular canals of the mouse ear. Mol. Cell. Biol. 22:2002;935-945
38. Wansa K.D.S.A., Harris J.M., Yan G., Ordentlicht P., Muscat G.E.O. The AF-1 domain of NOR-1/NR4A3 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine. J. Biol. Chem. 278:2003;24776-24790
39. Weiss S.W., Goldblum J.R. Enzinger and Weiss's Soft Tissue Tumors. 2001;1368-1379 Mosby, Saint-Louis
40. Bernier S.M., Goltzman D. Regulation of expression of the chondrocytic phenotype in a skeletal cell line (CFK2) in vitro. J. Bone Miner. Res. 8:1993;475-483
41. Henderson J.E., He B., Goltzman D., Karaplis A.C. Constitutive expression of parathyroid hormone-related peptide (PTHrP) stimulates growth and inhibits differentiation of CFK2 chondrocytes. J. Cell. Physiol. 169:1996;33-41
42. Henderson J.E., Naski M.C., Aarts M.M., Wang D., Cheng L., Goltzman D., Ornitz D.M. Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells. J. Bone Miner. Res. 15:2000;155-165
43. Panda D.K., Miao D., Lefebvre V., Hendy G.N., Goltzman D. The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells. J. Biol. Chem. 276:2001;41229-41236
44. Wilson T.E., Fahrner T.J., Johnston M., Milbrandt J. Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science. 252:1991;1296-1300
45. Atsumi T., Miwa Y., Kimata K., Ikawa Y. A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev. 30:1990;109-116
46. Eliazer S., Spencer J., Ye D., Olson E., Ilaria R.L. Alteration of mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing's sarcoma. Mol. Cell. Biol. 23:2003;482-492
47. Torchia E.C., Jaishankar S., Baker S.J. Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells. Cancer Res. 63:2003;3464-3468
48. Kuroda M., Ishada Y., Takanashi M., Satoh M., Machinami R., Watanabe T. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. Am. J. Pathol. 151:1997;735-744